Life Sciences Archive » August, 2009

Life Sciences - August, 2009

171 articles

• Walgreen Hits Cephalon Over Provigil Generic Deals
• Miss. AG Hits Teva, Other Pharmas With AWP Suit
• Wyeth Employees' Don, Doff Suit Moves To Trial
• CVS, Others Hit With Suit Over Generics Prices
• Ethicon Loses Bid To Toss Faulty Stapler Suit
• SEC Fraud Claims Against Ex-Centerpulse Exec Pared
• Wholesaler Denied JMOL In Suit Over Sanofi's Arava
• Boehringer IP Atty's Forced Retirement Ruled Illegal
• Derivative Suit Against Cephalon Board, CEO Tossed
• Zimmer, Smith Nephew Settle Bone Screw Patent Spat
• Nike, Adidas Slammed With Shoe Cushion Patent Suit
• Judge Keeps Neurontin Case Against Pfizer Intact
• 6th Circ. Affirms Dismissal Of Fen-Phen Case
• Kilpatrick Stockton Adds 2 Dickstein Insurance Attys
• Zimmer Slapped With Patent Suit Over Prosthetic Hips
• Bausch Wins Bid To Boot Expert From ReNu MDL
• FDA's Head Of Medical Devices Steps Down
• FDA Lacks Data To Back Funding Requests: Report
• Experts Call FDA's Device Approval Process Flawed
• Arnold & Porter Adds Antitrust Attys From Shearman
• Digitek Plaintiffs Must Produce Info
• FDA Restricts Clinical Trial Review Board Over Safety
• McKool Smith Adds Patent Litigator From Dewey
• Mass. AG Accuses Mylan, Others Of Medicaid Fraud
• Fed. Circ. Revives Part Of Ortho-McNeil Ultracet Saga
• Mallinckrodt Damages Limited In E-Z-EM Injector Spat
• Punitive Damages Bid Tossed In ObTape MDL
• 2nd Circ. Hands GSK A Win In Avandia Securities Suit
• Wyeth Loses Bid To Oust Howrey From Stent Suit
• FDA Reviewing Safety Of Popular Weight-Loss Drug
• Cipro Pay-For-Delay Deal Was Within Calif. Law: Court
• Allergan Warning May Prompt Suits By AGs: Expert
• HP, Others Sued Over Videoconferencing Patent
• Calif. Pharmacies Sue Pfizer Over Wyeth Merger
• Radiologist Targets Abbott Labs Over Stent Patent
• Citigroup Argues KV Pharma Knew ARS Risks
• Boston Scientific Stent Patent Spat Booted From Del.
• Considering Summary Judgment After KSR
• Warner Chilcott To Buy P&G Drug Biz For $3.1B
• Medtronic, WL Gore Settle Stent Patent Dispute
• Quebec Judge Rejects Class Action For Paxil Claims
• Qualitest Recalls Two Lots Of Insulin Syringes
• Nutracoastal Recalls, Stops Distributing 'Steam'
• Fed. Circ. To Revisit Ariad, Lilly IP Dispute En Banc
• LadaTech Sues Illumina Over DNA Analysis Patent
• Maximizing Biotech Patent Protection On A Budget
• Biovail's Hedge Fund Fraud Suit Gets Tossed
• Lilly To Pay $22.5M To Settle W.Va. Zyprexa Claims
• 9th Circ. Rejects Rehearing On Norvir Antitrust Deal
• Rite Aid, CVS Hit Cephalon With New Provigil Suit
• Federal Pleading After Twombly And Iqbal
• MediciNova, Avigen Merge To Boost Ibudilast Efforts
• No Brand Drugs For Iowa Medicaid Patients: 8th Circ.
• Plaintiffs To Appeal NY Ruling Over ReNu Solution
• FDA Warns Cos. About Marketing Ibuprofen Products
• Doctor's Deposition To Be Shown In Fosamax Trial
• Hamilton Brook Patent Attorney Moves To Foley
• Court Won't Change Inventorship In Zicam IP Suit
• Viagra MDL Plaintiffs Lose Star Expert Witness
• Bayer Dealt Blow In Nexavar Feud With Cipla
• Fed. Circ. Obviousness Vs. SCOTUS Precedent
• Method Patents Not Covered By 271(f): Fed. Circ.
• Merck Wins Block On Teva's Generic Singulair
• Fed. Circ. Upholds Wal-Mart Win In RFID Patent Suit
• Merck Seeks To Toss Doctor's Fosamax Testimony
• Neuralstem Asks Judge To Rethink Trade Libel Ruling
• Medicis Clears Up Acne Drug Dispute With Sandoz
• Health Fund Takes Seroquel Fraud Suit To 11th Circ.
• Synergetics Can't Claim Price Coercion In Alcon Suit
• Mylan Fights Decision Blocking Generic Benicar
• USPTO Grants Apotex's Bid To Review Plavix Patent
• Acacia Unit Drops Sun From Data Storage Patent Suit
• Medtronic Units Appeal Globus Patent Judgment
• Eli Lilly Method Patent For Gemzar Found Invalid
• Fen-Phen Atty Holds On To $5.7M Arbitration Award
• Drug Co-Op Accuses Boehringer Of Mirapex Monopoly
• Novo Fights To Nix Counterclaims In Prandin IP Suit
• The DOJ Stance On Reverse Payment Settlements
• Ex-Lawyers Get 20, 25 Years In Fen-Phen Fraud Case
• Purdue Pharma's Ultram Patents Deemed Invalid
• Gerber Aims To Wash Shampoo Action Out Of Its Hair
• High Court Asked To Limit Juries' Role In Patent Suits
• Bayer Sues J&J Unit Over Arthritis Drug
• Sanofi Appeal Puts Hospira's Generic Eloxatin On Hold
• Hospira Recalls Medical Devices For Faulty AC Cords
• Align Settles Orthodontics Patent War In $90M Deal
• GSK Sues Glenmark Over Malarone Patents
• Barr Recalls Oversized Adderall Batch
• Judge Greenlights Aredia Cases Against Novartis
• TET, Pharmasset Settle Spat Over Gene Test Patent
• Rite Aid, CVS File New HIV Drug Price Complaint
• NJ Judge Rejects 2nd Attempt To Certify Vioxx Action
• FDA Clears Mylan Over Ignored Computer Warnings
• Antitrust Suit Says Merck Blocking Generic Singulair
• Medline Sues 3M Over Hand Scrub Ads
• Demand For The Patented Product — Lower Bar?
• Covington Snags Ala. Atty Who Won Vioxx Suits
• Miller Canfield Picks Up Pfizer Patent Expert
• 1st Circ. Revives Qui Tam Claims Over Procrit AWP
• Sanofi, Watson Resolve Patent Dispute Over Plavix
• Opening Salvo Fired In Fosamax Trial
• Schering, Orchid Settle Clarinex Patent Suit
• FMLA And Equitable Estoppel
• Expert Testimony Excluded Again In Accutane MDL
• Merck Swaps Lead Attorney For Vioxx Appeal
• Cordis Stent Patents Found Enforceable On Remand
• Plaintiffs Reload In Cephalon Antitrust Litigation
• Ill. Enacts New Green Laws For Water, Drugs
• Obama Vows To Speed Generic-Drug Access
• Wellbutrin Plaintiffs Step Up Fight For Docs' Release
• Getting A Clean Safety Record Into Evidence In Calif.
• Bloomberg Wins Bid To Unseal Seroquel Docs
• Abbott Sues Centocor Over Psoriasis Drug Patents
• Judge Upholds Expanded Discovery In Digitek Case
• Watson Recalls Fentanyl Patches Due To Leak Risk
• Optometrist Makes Antitrust Claims In CIBA IP Suit
• FDA Speeds Up Disciplining Of Wayward Researchers
• Damages Litigation In UK Competition Cases
• Medical Device Maker Sued For Infringement, Libel
• Revisiting Ariad V. Eli Lilly
• Miss. AG's Suit Ousted From Vitamin MDL
• Bilski Test Stifles Innovation Across Industries: Briefs
• Subpoena Of Scientist Quashed In Fosamax MDL
• Zyprexa Failure-To-Warn Suit Survives In MDL
• FTC Seeks More Info On Watson, Arrow Merger
• Texas MDL Panel Consolidates Mylan Cases
• Q&A With Dickstein Shapiro's Gary Hoffman
• Court Approves $10M Settlement In Norvir Pricing Suit
• SEC Regulation Of Vote-Buying Scheme
• Making IP Litigation In Canada More Attractive
• Wyeth, Pfizer Resolve Investor Suits Over Merger
• Going In-House: Making The Transition From BigLaw
• Bilski Test Too Tough On Patent Eligibility: Briefs
• Teva Sues Merrill Over ARS Gone Bad
• Mayer Brown Snags Fish & Richardson IP Partner
• Elan Sues Over Biogen Objection To $1B J&J Deal
• Jury Hands Medtronic $57M In Alloy Suit Against AGA
• FDA Urges Melamine Testing On Drug Products
• India To Launch WTO Battle Over EU Drug Seizures
• FDA Head Promises Enforcement Crackdown
• C&D Appeals $29.2M Award In Pregnancy Test Suit
• Investors Hit Spectranetics With Fraud Suit
• Fed. Circ. Affirms Invalidity Of Bayer's Yasmin Patent
• Abbott To Try For Summary Judgment In TriCor Suit
• Merck, Schering Offer $42M To Settle Vytorin Suits
• Covidien Loses Bid To Block Generic Restoril
• J&J Unit Eyed Over Clinical Reviewers
• StemCells Claims Survive In Libel Suit Over IP Spat
• Q&A With Faegre & Benson's Joseph Price
• FDA Orders Cancer Warning For TNF Blockers
• Navinta Infringed Abraxis' Naropin Patents: Judge
• ICU, Medegen Settle IV Connection Patent Spat
• Daiichi Earns Win Against Mylan Over Benicar Patent
• Osteotech, RTI Near Deal In Bone Cleaning IP Suit
• Merck To Pay $80M To Settle Vioxx Suits
• J&J Hits CIBA Vision Over Contact Lens Patents
• FDA Halts Production Of Teva Animal Drugs
• Digitek MDL Claims Survive Motions To Dimiss
• Genzyme Hits Roxane With Suit Over Hectorol ANDA
• J&J Workers Renew Cert. Bid In Race Bias Action
• Squire Sanders Nabs Sughrue Mion IP Litigator
• Colgate Sues J&J Over Total Trademark
• La. Told To Produce Docs In Zyprexa MDL
• Swath Of Claims Cut From Wellbutrin Antitrust Action
• Why The ITC May Be Right For Your Chemicals Case
• FDA, EMEA Launch Clinical Trial Oversight Program
• Sun Pharma Settles Patent Suits Over Generic Ethyol
• House Panel Adds Pay-For-Delay Ban To Health Bill
• Clarcon Skin Products Seized Amid Bacteria Scare
• Thoratec, HeartWare Abandon Merger Talks
• GSK's Preemption Argument Fails To Stop Paxil Case